Project Search

Contextual Genomics has launched a National Access Project for Cancer Testing.  Currently, tumor testing is delivered by a disparate collage of academic laboratories.  This leads to non-scalable solutions and inequitable access to molecular testing across the country.

The project aimed to change clinical practice by allowing medication selection on the basis of an individual’s genetic tumor profile.  The test is for 90 actionable mutations and designed to increase availability, improve clinical outcomes and reduce costs. Also included is “best in market” patient safety, focused physician reporting, pricing designed for reimbursement in the Canadian market, and distribution by Canada’s largest laboratory, LifeLabs. The project was run by Contextual Genomics, in conjunction with UBC’s Personalized Medicine Initiative, several pharmaceutical companies, and clinical sites across Canada.